108 related articles for article (PubMed ID: 3660225)
1. [Equipment for rapid and reliable perineal implantation of I-125 seeds in prostatic cancer with reduced radiation exposure].
Bruggmoser G; Nanko N; Hempel M; Heitz R; Wannenmacher M
Strahlenther Onkol; 1987 Sep; 163(9):593-4. PubMed ID: 3660225
[TBL] [Abstract][Full Text] [Related]
2. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
[TBL] [Abstract][Full Text] [Related]
3. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
[TBL] [Abstract][Full Text] [Related]
4. Radiation exposure after permanent prostate brachytherapy.
Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
[TBL] [Abstract][Full Text] [Related]
5. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
[TBL] [Abstract][Full Text] [Related]
6. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
Cosset JM; Pinillos-Ashton L; Mettler F;
Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
[TBL] [Abstract][Full Text] [Related]
7. Contamination during a brachytherapy procedure.
Caldwell C; Sankreacha R; Lightstone AW; O'Brien P; Matheson C
Health Phys; 2007 Feb; 92(2 Suppl):S8-S12. PubMed ID: 17228191
[TBL] [Abstract][Full Text] [Related]
8. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy.
Al-Qaisieh B; Brearley E; St Clair S; Flynn A
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):304-7. PubMed ID: 16618585
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer.
Penfold SN; Marcu L; Lawson JM; Asp J
J Radiol Prot; 2012 Sep; 32(3):339-47. PubMed ID: 22854245
[TBL] [Abstract][Full Text] [Related]
10. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
11. [Brachycurie therapy of tumors--renaissance of a radio-oncologic method].
Sauer R; Thiel HJ; Müller R
Fortschr Med; 1982 Jun; 100(22):1047-53. PubMed ID: 7106669
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of the prostate: technics of curietherapy. Review of the literature and experience at the Institut Gustave-Roussy].
Chassagne D; Court B; Gerbaulet A; Perrin JL; Haie C
Bull Cancer; 1985; 72(6):578-84. PubMed ID: 4092108
[TBL] [Abstract][Full Text] [Related]
13. [Long-term radioactive implants in the therapy of prostate cancer. A new technic in radiotherapy].
Sommerkamp H; Knüfermann H; Wannenmacher M
Fortschr Med; 1981 Nov; 99(41):1696-9. PubMed ID: 7319439
[No Abstract] [Full Text] [Related]
14. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: radiation seed implantation without open surgery.
Gregory B; Van Valkenburgh J
J Post Anesth Nurs; 1989 Dec; 4(6):373-6. PubMed ID: 2480442
[No Abstract] [Full Text] [Related]
16. [Interstitial iodine 125 therapy in localized prostatic carcinoma. Results at the Utrecht University].
Battermann JJ
Praxis (Bern 1994); 2001 Sep; 90(36):1501-5. PubMed ID: 11593905
[TBL] [Abstract][Full Text] [Related]
17. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous fluoroscopically guided salvage of misplaced perirectal (125)I prostate seeds-easy way out.
Bangard C; Semrau R; Bovenschulte H; Lackner KJ
Urology; 2009 Oct; 74(4):924-5. PubMed ID: 19665215
[TBL] [Abstract][Full Text] [Related]
19. Quality assurance of I-125 seed permanent implant therapy using a self-color developing reflection-type dosimetry sheet film.
Furutani S; Ikushima H; Ozaki K; Oita M; Sasaki M; Takegawa Y; Nishitani H
Radiat Med; 2005 Nov; 23(7):474-7. PubMed ID: 16485537
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
Westendorp H; Hoekstra CJ; van't Riet A; Minken AW; Immerzeel JJ
Brachytherapy; 2007; 6(4):231-7. PubMed ID: 17991620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
